Anticancer and apoptotic activities of parthenolide in combination with epirubicin in mda-mb-468 breast cancer cells

[1]  E. Sauter.  Cancer prevention and treatment using combination therapy with natural compounds , 2020, Expert review of clinical pharmacology.

[2]  H. Arndt,et al.  Advances in chemistry and bioactivity of parthenolide. , 2019, Natural product reports.

[3]  R. Hoshyar,et al.  Effects of Combined Crocin and Epirubicin on Apoptosis and Cell Cycle Pathways in a Human Cervical Cancer Cell Line , 2018, International Journal of Cancer Management.

[4]  L. A. Al Kury,et al.  Parthenolide inhibits tumor-promoting effects of nicotine in lung cancer by inducing P53 - dependent apoptosis and inhibiting VEGF expression. , 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[5]  HoshyarReyhane,et al.  A Comparative Study on Anti-Invasion, Antimigration, and Antiadhesion Effects of the Bioactive Carotenoids of Saffron on 4T1 Breast Cancer Cells Through Their Effects on Wnt/β-Catenin Pathway Genes. , 2018 .

[6]  Si‐Yong Qin,et al.  Combinational strategy for high-performance cancer chemotherapy. , 2018, Biomaterials.

[7]  Qiang Z Yu,et al.  Parthenolide Inhibits STAT3 Signaling by Covalently Targeting Janus Kinases , 2018, Molecules.

[8]  Behzad Baradaran,et al.  Investigation of BAX and BCL2 expression and apoptosis in a resveratrol- and prednisolone-treated human T-ALL cell line, CCRF-CEM , 2018, Blood research.

[9]  S. Nazeri,et al.  Parthenolide reduces metastasis by inhibition of vimentin expression and induces apoptosis by suppression elongation factor α - 1 expression. , 2018, Phytomedicine : international journal of phytotherapy and phytopharmacology.

[10]  Hua Li,et al.  Parthenolide facilitates apoptosis and reverses drug-resistance of human gastric carcinoma cells by inhibiting the STAT3 signaling pathway , 2018, Oncology letters.

[11]  R. Hoshyar,et al.  Ziziphus Jujube: a review study of its anticancer effects in various tumor models invitro and invivo. , 2017, Cellular and molecular biology.

[12]  R. Safaralizadeh,et al.  The anti-proliferative and apoptotic effects of crocin on chemosensitive and chemoresistant cervical cancer cells. , 2017, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[13]  M. Kris,et al.  Targeting the differential addiction to anti-apoptotic BCL-2 family for cancer therapy , 2017, Nature Communications.

[14]  S. Prasad,et al.  Reactive oxygen species (ROS) and cancer: Role of antioxidative nutraceuticals. , 2017, Cancer letters.

[15]  N. Gray,et al.  Corrigendum: THZ1 targeting CDK7 suppresses STAT transcriptional activity and sensitizes T-cell lymphomas to BCL2 inhibitors , 2017, Nature Communications.

[16]  Bin Wang,et al.  Classification, Treatment Strategy, and Associated Drug Resistance in Breast Cancer. , 2016, Clinical breast cancer.

[17]  A. Zarban,et al.  The antioxidant and chemical properties of Berberis vulgaris and its cytotoxic effect on human breast carcinoma cells , 2016, Cytotechnology.

[18]  G. Buttitta,et al.  Parthenolide and DMAPT exert cytotoxic effects on breast cancer stem-like cells by inducing oxidative stress, mitochondrial dysfunction and necrosis , 2016, Cell Death and Disease.

[19]  G. Hortobagyi,et al.  Comparison of cardiac events associated with liposomal doxorubicin, epirubicin and doxorubicin in breast cancer: a Bayesian network meta-analysis. , 2015, European journal of cancer.

[20]  I. Kim,et al.  Balsalazide Potentiates Parthenolide-Mediated Inhibition of Nuclear Factor-κB Signaling in HCT116 Human Colorectal Cancer Cells , 2015, Intestinal research.

[21]  Y. Yang,et al.  Parthenolide induces autophagy via the depletion of 4E-BP1. , 2015, Biochemical and biophysical research communications.

[22]  V. Mathieu,et al.  Synthesis and biological evaluation of 9α- and 9β-hydroxyamino-parthenolides as novel anticancer agents. , 2014, Bioorganic & medicinal chemistry letters.

[23]  S. Seo,et al.  Parthenolide Sensitizes Human Colorectal Cancer Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand through Mitochondrial and Caspase Dependent Pathway , 2014, Intestinal research.

[24]  I. Kim,et al.  Synergistic antitumor effect of 5-fluorouracil in combination with parthenolide in human colorectal cancer. , 2013, Cancer letters.

[25]  A. Janecka,et al.  Apoptosis-mediated cytotoxic effects of parthenolide and the new synthetic analog MZ-6 on two breast cancer cell lines , 2012, Molecular Biology Reports.

[26]  Wonyong Kim,et al.  Combined Effect of Hsp90 Inhibitor Geldanamycin and Parthenolide via Reactive Oxygen Species‐Mediated Apoptotic Process on Epithelial Ovarian Cancer Cells , 2012, Basic & clinical pharmacology & toxicology.

[27]  P. Vandenabeele,et al.  Sesquiterpene lactones as drugs with multiple targets in cancer treatment: focus on parthenolide , 2012, Anti-cancer drugs.

[28]  Liping Xie,et al.  Parthenolide Induces Apoptosis and Cell Cycle Arrest of Human 5637 Bladder Cancer Cells In Vitro , 2011, Molecules.

[29]  Russell J. Mumper,et al.  Plant Phenolics: Extraction, Analysis and Their Antioxidant and Anticancer Properties , 2010, Molecules.

[30]  A. Bishayee,et al.  d-Limonene sensitizes docetaxel-induced cytotoxicity in human prostate cancer cells: Generation of reactive oxygen species and induction of apoptosis , 2009, Journal of carcinogenesis.

[31]  S. Elmore.  Apoptosis: A Review of Programmed Cell Death , 2007, Toxicologic pathology.

[32]  W. Rzeski,et al.  Antiproliferative activity of parthenolide against three human cancer cell lines and human umbilical vein endothelial cells. , 2007, Pharmacological reports : PR.

[33]  M. Y. Hanafi-Bojd,et al.  Surface functionalized mesoporous silica nanoparticles as an effective carrier for epirubicin delivery to cancer cells. , 2015, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[34]  M. Karbakhsh,et al.  Twenty years of breast cancer in Iran: downstaging without a formal screening program. , 2011, Annals of oncology : official journal of the European Society for Medical Oncology.

[35]  Y. Doki,et al.  Parthenolide, an NF-κB inhibitor, suppresses tumor growth and enhances response to chemotherapy in gastric cancer. , 2011, Cancer genomics & proteomics.

[36]  A. Jemal,et al.  Global Cancer Statistics , 2011 .

[37]  D. Leibfritz,et al.  Free radicals and antioxidants in normal physiological functions and human disease. , 2007, The international journal of biochemistry & cell biology.